Balev M, Zibara V, Van Hyfte G, Feld J, et al. Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia. Am J Hematol 2024 Jul 5. doi: 10.1002/ajh.27429.
PMID: 38970273